Table 17. Analysis of changes in CK2 gene expression in testicular cancer.
Gene | p-value | Fold Change | Rank (Top %) | Dataset | #Samples | Reference |
---|---|---|---|---|---|---|
Testicular Seminoma | ||||||
CK2α | 0.003 | -1.645 | 22% | Sperger Others | 74 | [142] |
CK2α’ | 0.009 | -1.640 | 27% | Sperger Others | 74 | [142] |
CK2β | 0.012 | 2.607 | 9% | Skotheim Testis | 30 | [143] |
CK2αP | 0.003 | -1.645 | 22% | Sperger Others | 74 | [142] |
Seminoma, Not Otherwise Specified | ||||||
CK2α | 1.21 10−5 | -2.224 | 13% | Korkola Seminoma | 107 | [144] |
CK2α’ | 8.56 10−11 | -8.257 | 1% | Korkola Seminoma | 107 | [144] |
CK2β | 2.11 10−6 | -2.180 | 10% | Korkola Seminoma | 107 | [144] |
Testicular Teratoma | ||||||
CK2α’ | 0.006 | -4.093 | 7% | Skotheim Testis | 30 | [143] |
CK2β | 0.009 | -2.471 | 9% | Skotheim Testis | 30 | [143] |
Teratoma, Not Otherwise Specified | ||||||
CK2α | 3.56 10−9 | -3.805 | 4% | Korkola Seminoma | 107 | [144] |
CK2α’ | 5.12 10−12 | -9.860 | 1% | Korkola Seminoma | 107 | [144] |
CK2β | 3.93 10−8 | -2.791 | 6% | Korkola Seminoma | 107 | [144] |
Embryonal Carcinoma, Not Otherwise Specified | ||||||
CK2α | 5.98 10−8 | -2.666 | 6% | Korkola Seminoma | 107 | [144] |
CK2α’ | 6.42 10−12 | -9.596 | 1% | Korkola Seminoma | 107 | [144] |
CK2β | 1.59 10−6 | -2.349 | 11% | Korkola Seminoma | 107 | [144] |
Mixed Germ Cell Tumor, Not Otherwise Specified | ||||||
CK2α | 1.25 10−7 | -2.302 | 10% | Korkola Seminoma | 107 | [144] |
CK2α’ | 4.33 10−12 | -7.593 | 3% | Korkola Seminoma | 107 | [144] |
CK2β | 6.47 10−7 | -2.377 | 12% | Korkola Seminoma | 107 | [144] |
Yolk Sac Tumor, Not Otherwise Specified | ||||||
CK2α | 0.014 | -1.524 | 30% | Korkola Seminoma | 107 | [144] |
CK2α’ | 1.21 10−9 | -6.599 | 1% | Korkola Seminoma | 107 | [144] |
CK2β | 9.08 10−5 | -2.123 | 15% | Korkola Seminoma | 107 | [144] |